AI assistant
Nukkleus Inc. — Director's Dealing 2025
Dec 31, 2025
34615_dirs_2025-12-31_1bb1a574-b06f-437c-95f7-1e5e37e9d47c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Nukkleus Inc. (NUKK)
CIK: 0001787518
Period of Report: 2025-12-22
Reporting Person: Kotaieva Anastasiia (See Remarks below)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-12-22 | Common Stock, $0.0001 par value per share | S | 30000 | $4.4146 | Disposed | 1331197 | Indirect |
| 2025-12-23 | Common Stock, $0.0001 par value per share | S | 70000 | $4.5726 | Disposed | 1261197 | Indirect |
| 2025-12-24 | Common Stock, $0.0001 par value per share | S | 55604 | $4.4894 | Disposed | 1205593 | Indirect |
| 2025-12-26 | Common Stock, $0.0001 par value per share | S | 55604 | $4.2629 | Disposed | 1149989 | Indirect |
Footnotes
F1: The reported price is a weighted average price per share. These shares were sold in multiple transactions ranging from $4.49 to $4.415, inclusive. The reporting person undertakes to provide Nukkleus Inc., any security holder of Nukkleus Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F2: Anastasiia Kotaieva is the owner of X Group Fund of Funds Limited Partnership.
F3: The reported price is a weighted average price per share. These shares were sold in multiple transactions ranging from $4.905 to $4.41, inclusive. The reporting person undertakes to provide Nukkleus Inc., any security holder of Nukkleus Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F4: The reported price is a weighted average price per share. These shares were sold in multiple transactions ranging from $4.47 to $4.23, inclusive. The reporting person undertakes to provide Nukkleus Inc., any security holder of Nukkleus Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F5: The reported price is a weighted average price per share. These shares were sold in multiple transactions ranging from $4.48 to $4.41, inclusive. The reporting person undertakes to provide Nukkleus Inc., any security holder of Nukkleus Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.